INTRODUCTION
Kyphoplasty, which involves the use of a balloon tamp to expand fractured bone, and the use of Kyphon's proprietary technology for this procedure,
is experiencing rapid uptake, with the company's sales increasing over 100% from 2001 to 2002. The use of vertebroplasty and kyphoplasty will increase
as new products are introduced, and treatment continues to move away from more conservative efforts.
SCOPE OF THE REPORT
- Forecast of 2003 Kyphon sales and kyphoplasties
- Analysis of potential for future growth of kyphoplasty market, and recommendations for competitors and competitive products
- Comparison of vertebroplasty and kyphoplasty in terms of safety, efficacy, and cost/reimbursement issues
- Analysis of factors that will affect the market for spinal compression repair procedures over the next several years
REPORT HIGHLIGHTS
Increasing use of surgical intervention to treat vertebral compression fractures is occurring at the expense of bed rest and pain management, as
surgeons expect conservative treatment to decrease 40% in the next two years
Kyphon sales will likely outperform management guidance this year, as
the number of kyphoplasty procedures performed will approach 28,000 in 2003
Companies with vertebroplasty-specific products must increase surgeon
awareness through focused marketing
KEY REASONS TO BUY THIS REPORT
- Understand surgeon opinion on kyphoplasty and vertebroplasty, in terms of usage, safety, efficacy, and cost.
- Identify potential for vertebroplasty systems, and related products, based on uptake of surgical intervention in vertebral compression
fractures.
Overview
Introduction
tbc
DRIVERS AND TRENDS
Vertebroplasty, a minimally-invasive procedure that involves the injection of a formulated bone cement mixture into the fracture,
has gained acceptance as an effective method of treating spinal compression fractures after conservative efforts have failed. Meanwhile, kyphoplasty,
which involves the use of a balloon tamp to expand the fractured bone, and the use of Kyphon’s proprietary technology for this procedure, is
experiencing rapid uptake. The use of both procedures could increase as new products are introduced, and treatment continues to move away from more
conservative efforts.
MARKET OVERVIEW
A look at kyphoplasty and vertebroplasty procedures, and the sales performance of Kyphon.
- Datamonitor believes that Kyphon will outperform management guidance in 2003
- What factors have the potential to slow uptake of kyphoplasty in the near future?
TRENDS AND OPINIONS IN KYPHOPLASTY
Insight into the thoughts of experienced spinal surgeons on the pros and cons of kyphoplasty and vertebroplasty
- Which procedure is safer? More effective?
- How will treatment patterns change over the next three years?
- How do cost and reimbursement impact surgeon choice?
DATASETS
- Table 1: Historical and Forecast sales for the KyphX IBT product
- Table 2: Prevalence of osteopororis and osteopenia, seven major markets, 2002-2010
- Table 3: Over the course of the next few years, what percentage of patients suffering from spinal compression fractures that are admitted to
your hospital do you expect will be treated with the following procedures?
- Table 4: In your opinion, what percentage of the diagnosed population would be adequately treated with bed rest?
- Table 5: What (if any) complications have you encountered when using the KyphX IBT system?
- Table 6: What is the average cost and Medicare reimbursement rate in your state per procedure for the following products?
- Table 7: Procedural reimbursement for KyphX IBT versus vertebroplasty procedures